Imperial College London
Alternate

ProfessorRolandVeltkamp

Faculty of Medicine, Department of Brain Sciences

Professor of Neurology and Chair of Stroke Medicine
 
 
 
//

Contact

 

r.veltkamp

 
 
//

Location

 

3 East6East WingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Wutzler:2019:10.1186/s12883-019-1249-y,
author = {Wutzler, A and Krogias, C and Grau, A and Veltkamp, R and Heuschmann, PU and Haeusler, KG},
doi = {10.1186/s12883-019-1249-y},
journal = {BMC Neurology},
title = {Stroke prevention in patients with acute ischemic stroke and atrial fibrillation in Germany - a cross sectional survey},
url = {http://dx.doi.org/10.1186/s12883-019-1249-y},
volume = {19},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BackgroundAtrial fibrillation (AF) is present in 15–20% of patients with acute ischemic stroke. Oral anticoagulation reduces the risk of AF-related recurrent stroke but clinical guideline recommendations are rather vague regarding its use in the acute phase of stroke. We aimed to assess the current clinical practice of medical stroke prevention in AF patients during the acute phase of ischemic stroke.MethodsIn April 2017, a standardized anonymous questionnaire was sent to clinical leads of all 298 certified stroke units in Germany.ResultsOverall, 154 stroke unit leads participated (response rate 52%). Anticoagulation in the acute phase of stroke is considered feasible in more than 90% of AF patients with ischemic stroke. Clinicians assume that about two thirds of all AF patients (range 20–100%) are discharged on oral anticoagulation. According to local preferences, acetylsalicylic acid is given orally in the majority of patients with delayed initiation of oral anticoagulation. A non-vitamin K-dependent oral anticoagulant (NOAC) is more often prescribed than a vitamin K-dependent oral anticoagulant (VKA). VKA is more often chosen in patients with previous VKA intake than in VKA naive patients. In the minority of patients, stroke unit leads discuss the prescription of a specific oral anticoagulant with the treating general practitioner. Adherence to medical stroke prevention after hospital discharge is not assessed on a regular basis in any patient by the majority of participating stroke centers.ConclusionsEarly secondary stroke prevention in AF patients in German stroke units is based on OAC use but prescription modalities vary in clinical practice.
AU  - Wutzler,A
AU  - Krogias,C
AU  - Grau,A
AU  - Veltkamp,R
AU  - Heuschmann,PU
AU  - Haeusler,KG
DO  - 10.1186/s12883-019-1249-y
PY  - 2019///
SN  - 1471-2377
TI  - Stroke prevention in patients with acute ischemic stroke and atrial fibrillation in Germany - a cross sectional survey
T2  - BMC Neurology
UR  - http://dx.doi.org/10.1186/s12883-019-1249-y
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458733300002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - http://hdl.handle.net/10044/1/70543
VL  - 19
ER  -
Download